Marcus M. Schittenhelm

Dasatinib (BMS-354825), a Dual SRC/ABL Kinase Inhibitor, Inhibits the Kinase Activity of Wild-Type, Juxtamembrane, and Activation Loop Mutant KIT Isoforms Associated with Human Malignancies

Marcus M. Schittenhelm, Sharon Shiraga, Arin Schroeder et al. · Cancer Research · 2006 · 466 citations

Clonal evolution in relapsed NPM1-mutated acute myeloid leukemia

Jan Krönke, Lars Bullinger, Veronica Teleanu et al. · Blood · 2013 · 263 citations

Identification of Driver and Passenger Mutations of FLT3 by High-Throughput DNA Sequence Analysis and Functional Assessment of Candidate Alleles

Stefan Fröhling, Claudia Scholl, Ross L. Levine et al. · Cancer Cell · 2007 · 195 citations · Full text

Genetic Analysis, Functional Assessment, Allelic Variant +11

Functional response of leukaemic blasts to stromal cell‐derived factor‐1 correlates with preferential expression of the chemokine receptor CXCR4 in acute myelomonocytic and lymphoblastic leukaemia

Robert Möhle, Marcus M. Schittenhelm, Cornelia Failenschmid et al. · British Journal of Haematology · 2000 · 145 citations · Full text

Efficacy of cytotoxic agents used in the treatment of testicular germ cell tumours under normoxic and hypoxic conditions in vitro

Sandra Koch, Frank Mayer, Friedemann Honecker et al. · British Journal of Cancer · 2003 · 123 citations · Full text